Lavipharm (FRA:BXA0) ROE % Adjusted to Book Value : 11.95% (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Lavipharm ROE % Adjusted to Book Value?

Lavipharm's ROE % for the quarter that ended in Jun. 2024 was 32.99%. Lavipharm's PB Ratio for the quarter that ended in Jun. 2024 was 2.76. Lavipharm's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was 11.95%.

Lavipharm ROE % Adjusted to Book Value Historical Data

The historical data trend for Lavipharm's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lavipharm ROE % Adjusted to Book Value Chart

Lavipharm Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

Negative Equity

2.20

1.50

Lavipharm Semi-Annual Data
	Dec17	Dec18	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial						Negative Equity	-5.30	4.49	-0.54	11.95

Competitive Comparison of Lavipharm's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Lavipharm's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lavipharm's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lavipharm's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Lavipharm's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Lavipharm ROE % Adjusted to Book Value Calculation

Lavipharm's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	4.51%	/	3.01
	=	1.50%

Lavipharm's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	32.99%	/	2.76
	=	11.95%

Lavipharm ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Lavipharm's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Lavipharm Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lavipharm SA (FRA:BXA0) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

LAVI:Greece

Address

Agias Marinas Street, PO Box 59, Peania Attica, GRC, 19002

Website

http://www.lavipharm.com

Lavipharm SA develops, manufactures, markets and distributes pharmaceutical, cosmetic and consumer health products in Greece and internationally. The company's product portfolio includes safe and effective therapeutic solutions that meet consumer' needs for health and wellbeing. Its main product categories are Cardiology, Oncology, Urology, Neurology, Psychiatry, General Medicine, Self- Treatment and Dermocosmetic care.

Lavipharm Headlines

No Headlines